The draft recommendation calls for screening patients ages 35 to 70 years who are overweight or obese. It is open for public comment through Monday, April 12.
A recent meta-analysis from Denmark looked at patients with genetic variations that cause increases in plasma glucose levels and found that their elevated ischemic stroke risk appeared to be mitigated by treatment with certain classes of diabetes drugs.
Amputations among U.S. patients with diabetes decreased between 2000 and 2009 but increased by 50% from 2009 to 2015, leading the American Heart Association (AHA) to call for better identification and treatment of peripheral artery disease and propose policy solutions.
Several recent studies have found evidence that outcomes from COVID-19 differ by the diabetes medications patients were taking before they got sick, including metformin being associated with better outcomes, but confounding by indication is likely, researchers noted.
The April ACP Internist looked at two issues related to diabetes— the high prevalence of nonalcoholic fatty liver disease (NAFLD) and how some internists have succeeded in getting their patients to exercise more.